Showing results (71-80 of 87) with videos related to
Sort By:
Pageof 9
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 15, 2015
Essential role of mitochondrial energy metabolism in Foxp3⁺ T-regulatory cell function and allograft survivalUlf H Beier, Alessia Angelin, Tatiana Akimova, et al.Molecular Metabolism|August 8, 2022
Nicotinamide riboside alleviates exercise intolerance in ANT1-deficient micePatrick M Schaefer, Jessica Huang, Arrienne Butic, et al.Science Translational Medicine|February 15, 2019
Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancerSunil Singhal, Jason Stadanlick, Michael J Annunziata, et al.Transplantation|April 30, 2024
Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic Ischemia-Reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger Ubiquitin-binding DomainSeth J Concors, Paul T Hernandez, Ciaran O'Brien, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 14, 2018
Loss of HDAC6 alters gut microbiota and worsens obesityArnon D Lieber, Ulf H Beier, Haiyan Xiao, et al.Molecular Metabolism|February 10, 2025
ACC1 is a dual metabolic-epigenetic regulator of Treg stability and immune tolerancePhilipp Stüve, Gloria J Godoy, Fernando N Ferreyra, et al.Contemporary Clinical Trials Communications|December 16, 2025
Impact of updated regulatory guidelines on study results in contemporary uncomplicated urinary tract infection clinical trials and implications for trial conduct and drug development: a comparative analysis with EAGLE-2 and EAGLE-3Florian Wagenlehner, Keith S Kaye, David A Talan, et al.Ebiomedicine|October 30, 2016
Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3+ T-regulatory Cell Function and Promotes Antitumor ImmunityLiqing Wang, Suresh Kumar, Satinder Dahiya, et al.Scientific Reports|April 28, 2021
HDAC2 targeting stabilizes the CoREST complex in renal tubular cells and protects against renal ischemia/reperfusion injuryDavid D Aufhauser, Paul Hernandez, Seth J Concors, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2026
Subgroup Analysis of Pooled Phase 3 Efficacy Data from Two Randomized Trials of Gepotidacin Versus Nitrofurantoin in Uncomplicated Urinary Tract Infections (EAGLE-2 and EAGLE-3) including Participants with Uropathogens Not-Susceptible to NitrofurantoinAmanda Sheets, Jeremy Dennison, Jennifer H Han, et al.Pageof 9